Acceder

Publicaciones - CARDIOLOGIA CLINICA Y EXPERIMENTAL

Cargando...
Ray KK, Colhoun HM, Szarek M, Baccara-Dinet M, Bhatt DL, Bittner VA, Budaj AJ, Diaz R, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Loizeau V, Lopes RD, Moryusef A, Murin J, Pordy R, Ristic AD, Roe MT, Tunon J, White HD, Zeiher AM, Schwartz GG, Steg PG; ODYSSEY OUTCOMES Committees and Investigators. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial. Lancet Diabetes Endocrinol. 2019 Aug;7(8):618-628. doi: 10.1016/S2213-8587(19)30158-5. Epub 2019 Jul 1. Erratum In: Lancet Diabetes Endocrinol. 2019 Jul 8;: Lancet Diabetes Endocrinol. 2019 Sep;7(9):e21. PubMed PMID: 31272931.
AÑO: 2019; IF: 25.34
Lane DA, Dagres N, Dan GA, Garcia Seara J, Iliodromitis K, Lenarczyk R, Lip GYH, Mansourati J, Marin F, Scherr D, Potpara TS. Antithrombotic treatment in patients with atrial fibrillation and acute coronary syndromes: results of the European Heart Rhythm Association survey. Europace. 2019 Jul 1;21(7):1116-1125. doi: 10.1093/europace/euz033. PubMed PMID: 30874724.
AÑO: 2019; IF: 4.045
Vera-Catalan T, Gallego-Gomez JI, Rivera-Caravaca JM, Segura-Melgarejo F, Rodriguez-Gonzalez-Moro MT, Simonelli-Munoz AJ. A new tool to assess patients' comfort during hospitalization: The Hospital Discomfort Risk questionnaire. J Nurs Manag. 2019 Oct;27(7):1485-1491. doi: 10.1111/jonm.12834. PubMed PMID: 31349371.
AÑO: 2019; IF: 2.243
Martinez-Milla J, Raposeiras-Roubin S, Pascual-Figal DA, Ibanez B. Role of Beta-blockers in Cardiovascular Disease in 2019. Rev Esp Cardiol (Engl Ed). 2019 Oct;72(10):844-852. doi: 10.1016/j.rec.2019.04.014. Epub 2019 Aug 8. English, Spanish. PubMed PMID: 31402328.
AÑO: 2019; IF: 4.642
Pastor-Perez FJ, Garcia-Alberola A, Navarro-Penalver M, Goya-Esteban R, Garrido-Bravo IP, Barquero-Perez O, Rojo-Alvarez JL, Pascual-Figal DA. Lack of improvement in autonomic cardiac tone after sacubitril/valsartan at lower than target doses. J Electrocardiol. 2019 Jan-Feb;52:99-100. doi: 10.1016/j.jelectrocard.2018.11.015. Epub 2018 Nov 28. PubMed PMID: 30529813.
AÑO: 2019; IF: 0.944
< AnteriorSiguiente >

Instituto de Investigación Sanitaria Acreditado

ISCII